Title: Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
14048-30-7
14687-15-1
14168-65-1
16232-91-0
201595-65-5
20942-99-8
56193-21-6 | Cephalexin Sulfoxide | AA00DFF1 | MFCD21363511
51833-76-2 | ANGIOTENSIN 1/2 + A (2 - 8) | AA00DFMN | MFCD08274177
55775-97-8 | 2,6-dichloro-3-nitrobenzoic acid | AA00DFYK | MFCD00075422
53698-46-7 | 2-Methoxy-4-phenylpyridine | AA00DG8D | MFCD11044372
445441-27-0 | 1-Methyl-3-(1-methyl-4-piperindin-4-yl)-5-hydroxy-1H-indole2,6-difluorobenzenesulfonicacidesteroxalate | AA00DGQ1 | MFCD18384957
438539-71-0 | 2-Fluoro-5-Methylbenzenesulfonamide | AA00DHE2 | MFCD16038692
439146-20-0 | 6-Chloro-4-methoxypyridin-2-amine | AA00DHTB | MFCD18415424
53995-97-4 | Isoindolin-2-amine hydrochloride | AA00DHYJ | MFCD18206755
460748-71-4 | 4-[2-[2-[(2R)-2-Methyl-1-pyrrolidinyl]ethyl]-5-benzofuranyl]benzonitrile tartrate | AA00DIEM | MFCD18089823
473249-36-4 | 1-propylpyrazole-4-carbaldehyde | AA00DITA | MFCD03727244